NEW YORK (GenomeWeb) – Bruker reported after the close of the market Thursday that revenues in the third quarter grew 11 percent to $435.6 million from $393.9 million in Q3 2016, beating the consensus Wall Street estimate of $414.6 million.

Excluding a nearly 5 percent positive effect from acquisitions and a more than 2 percent boost from currency effects, the company posted Q3 organic growth of 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.